Global Cosmetics News – Weekly Review | Week 45, November 2026
AIThis post was created with the assistance of artificial intelligence (AI).

TL;DR

Before you orderOffer from Amazon

Get beauty and skincare favorites delivered free with Prime

  • Fast, free delivery on millions of items
  • Prime Video, Amazon Music and more included
  • Member-only deals all year
Start your free Prime trial Free trial for eligible customers · Cancel anytime
As an affiliate, we earn on qualifying purchases.

The Week 45 cosmetics review reported acquisitions and potential bids alongside sharply mixed company results, restructuring plans and investment in research and digital tools. Kimberly-Clark completed its acquisition of Kenvue, while PAI Partners agreed to acquire Elemis from L’Occitane Group. The review also highlighted unresolved questions about deal terms, bidder interest and whether sales growth can translate into stronger profitability.

Global Cosmetics News’ Week 45, November 2026 review reported a busy period for the cosmetics and personal care industry, led by Kimberly-Clark’s completed acquisition of Kenvue and PAI Partners’ agreement to acquire Elemis from L’Occitane Group. The week also showed sharply different company results and new investment in research, technology and restructuring, highlighting the pressure on businesses to pair growth with profitability.

The review identified mergers and acquisitions as a central theme. Kimberly-Clark completed its acquisition of Kenvue, adding brands including Neutrogena and Johnson’s Baby to its portfolio. Separately, PAI Partners agreed to acquire Elemis from L’Occitane Group, with plans to accelerate the skincare brand’s international growth. CVC, Cinven and Puig were reported as potential bidders for fragrance house Parfums de Marly; the review did not describe a completed sale.

Results varied across the companies covered. e.l.f. Beauty reported 51% sales growth and raised its outlook, while Estée Lauder reported a 7% sales increase and upgraded its forecast. Kenvue said its Skin Health and Beauty division grew 5.1%, and APR Corporation reported revenue growth of 100.3%, supported by international demand. Elsewhere, Coty’s sales fell 1%, The Honest Company’s revenue declined 8.6% despite a higher full-year outlook, and Amorepacific’s profit fell 14.3% despite sales growth. Proya reported revenue growth of 29.8%, with higher marketing spending weighing on profitability, according to the review.

Companies also outlined plans for cost control and investment. Unilever set out a restructuring programme targeting €1 billion in savings and committed €35 million to its Indian research and development facilities, including work in AI-driven product development, biotechnology and fragrance. Estée Lauder established growth and profitability targets through 2030 and extended its AI partnership with Microsoft. Maybelline introduced a virtual make-up try-on experience through ChatGPT. Other developments included Coty’s 40-year extension of its Marc Jacobs licence, retail and distribution expansion in India and South Korea, leadership appointments, and a UK campaign warning about counterfeit cosmetics.

At a glance
recapWhen: Week 45, November 2026
The developmentGlobal Cosmetics News’ Week 45 review brought together acquisition activity, contrasting financial results and investments in research, AI and international expansion across the cosmetics and personal care sector.

Growth Meets Profitability Pressure

The week’s results underline that sales growth alone does not settle the performance question. Some companies raised forecasts after strong increases, while others reported falling sales or profits, or faced cost pressure from marketing. Proya’s reported revenue growth alongside lower profitability illustrates the tension between pursuing expansion and controlling expenditure. The review does not provide comparable company-level margins or a common reporting period for every figure, so the numbers should not be treated as a direct ranking.

Ownership changes could also reshape brand strategy and distribution. The completed Kenvue acquisition changes the corporate portfolio around well-known consumer health and beauty brands, while the proposed Elemis deal points to a new owner’s stated ambition for international growth. Meanwhile, spending on AI and research suggests companies are testing how technology can support product development and consumer discovery. Whether those investments produce measurable commercial returns remains an open question.

Products Worth Considering

Philips Sonicare 5950 Rechargeable Electric Toothbrush with 2 Brush Heads, Pink

Philips Sonicare 5950 Rechargeable Electric Toothbrush with 2 Brush Heads, Pink

Hyperice Hypervolt 3 Percussion Massage Gun with Heated Head and Carry Case

Hyperice Hypervolt 3 Percussion Massage Gun with Heated Head and Carry Case

As an affiliate, we earn on qualifying purchases.

Deals and Investment Across Markets

The review brings together developments from several parts of the beauty business: skincare and fragrance transactions, mass-market and prestige company results, product innovation, retail expansion and consumer protection. Its account distinguishes a completed Kenvue acquisition from the agreed Elemis deal and from the reported potential interest in Parfums de Marly. Those statuses matter: a completed transaction is different from an agreement still subject to its next steps or an unconfirmed bidding process.

Investment and restructuring also appeared alongside brand partnerships and leadership changes. Unilever’s savings target and Indian R&D commitment show how cost programmes and research spending can proceed at the same time. The review also reported Estée Lauder’s long-term targets and AI collaboration, Coty’s extended Marc Jacobs agreement, and Chanel’s expanded cultural partnership with M+ in Hong Kong. A UK campaign against counterfeit cosmetics added a consumer-safety dimension to the business news.

Deal Status and Returns Ahead

The source review does not give financial terms, closing conditions or completion dates for the Elemis transaction, nor does it say whether the possible Parfums de Marly bidders made formal offers. It also does not provide details about regulatory approvals or integration plans for Kimberly-Clark’s completed Kenvue acquisition.

For the results and investments, the review offers selected growth rates but not full earnings statements, consistent comparison periods or detailed forecasts for every company. It is not yet clear how the announced restructuring savings will be delivered, how AI projects will affect revenue or costs, or whether higher marketing expenditure will support lasting growth. The UK counterfeit campaign’s specific enforcement measures and reach are also not detailed.

Transactions and Targets to Track

Near-term developments to watch include whether the Elemis acquisition progresses to completion and whether the reported interest in Parfums de Marly leads to formal bids or a sale process. Kimberly-Clark’s next disclosures may provide more information about how Kenvue’s brands fit into its portfolio. The source review does not set dates for those milestones.

Investors and industry observers can also follow future company results for evidence on profitability, marketing costs and restructuring savings, as well as updates on Unilever’s R&D programme and Estée Lauder’s AI work. Companies’ performance against their stated targets will clarify whether investment and expansion are translating into durable commercial results.

Key Questions

What was the biggest completed deal in the Week 45 review?

Kimberly-Clark completed its acquisition of Kenvue, bringing brands including Neutrogena and Johnson’s Baby into its portfolio, according to Global Cosmetics News.

Was the Elemis acquisition completed?

The review says PAI Partners agreed to acquire Elemis from L’Occitane Group. It does not say the transaction had been completed or provide a closing date.

Which companies reported growth?

The review reported sales growth at e.l.f. Beauty, Estée Lauder and Kenvue’s Skin Health and Beauty division, and revenue growth at APR Corporation and Proya. The companies’ figures cover different measures and should not be treated as directly comparable.

What technology investments or launches were reported?

Unilever committed €35 million to Indian R&D facilities with work spanning AI-driven product development, biotechnology and fragrance. Estée Lauder extended its AI partnership with Microsoft, and Maybelline launched a virtual make-up try-on experience through ChatGPT.

What remains uncertain after the weekly review?

The review does not confirm the status or terms of a Parfums de Marly sale, give a completion date for the Elemis deal, or detail the commercial returns expected from the companies’ technology and restructuring plans.

Source: globalcosmeticsnews.com

Wellness content on this site is informational and not a substitute for professional medical guidance.
You May Also Like

Space NK’s Comparable Turnover Surges 19% As Ulta Beauty Acquisition And New Stores Drive Sales

Space NK reported £282.7m in comparable turnover over 44 weeks, while operating profit fell amid acquisition-related costs.

Zendaya Is Goddess-Like in This Sculpted, Beaded, Fantastic Schiaparelli Gown

Zendaya stuns in a sculpted, beaded Schiaparelli gown, drawing widespread attention for her striking appearance at the recent event.

Hugo Boss Surges In Global Coverage

Hugo Boss has seen a significant increase in media mentions worldwide, with 23 mentions in recent coverage, indicating heightened global interest.

Consumers Enter Their High-Low Beauty Era 08/12/2026

In 2026, consumers are shifting towards a high-low beauty trend, blending luxury and affordability. Experts see this as a significant change in beauty standards.